Get started
Author

Yasmin Sánchez‐Pearson

Observed names: Yasmin Sanchez-Pearson, Yasmin Sánchez-Pearson
ORCID: 0009-0007-6216-6291
Observed ORCID: 0009-0007-6216-6291
OpenAlex ID: A5031982209
Safety and immunogenicity of a booster dose of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 2, open-label extension of a phase 1/2 randomised controlled trial
2025 · Babalwa Jongihlati, Nathan Segall, et al. · The Lancet Infectious Diseases · 10
Violation of the 12/23 rule of genomic V(D)J recombination is common in lymphocytes
2014 · Nicholas J. Parkinson, Matthew Roddis, et al. · Genome Research · 5
PDF
173. Oral Tebipenem Pivoxil Hydrobromide versus Intravenous Imipenem-Cilastatin in Patients with Complicated Urinary Tract Infections or Acute Pyelonephritis: Efficacy and Safety Results from the Phase 3 PIVOT-PO study
2026 · David K Hong, Sibel Ascioglu, et al. · Open Forum Infectious Diseases · 4
Pharmacokinetics of the Monoclonal Antibody, Sotrovimab, in Healthy Participants Following IM Administration at Different Injection Sites
2024 · Asma El‐Zailik, Jennifer Sager, et al. · Clinical Pharmacology & Therapeutics · 2
Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study
2025 · Jennifer Moore, Alicia Aylott, et al. · mAbs · 1
517. Safety and Tolerability of Intramuscular (IM) Sotrovimab 500 mg Administered at Different Injection Sites: Results from the Phase I COSMIC Study
2023 · Jennifer Moore, Wen-Hung Chen, et al. · Open Forum Infectious Diseases · 1
PDF
Safety, Tolerability and Pharmacokinetics of a High-Dose, Rapid-Infusion Monoclonal Antibody: Phase I Results for Intravenous Sotrovimab 3000 mg
2025 · Yasmin Sánchez-Pearson, Jennifer Moore, et al. · Drugs in R&D
PDF
2134. A Phase 2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Booster Dose of a Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine (GBS6)
2022 · Babalwa Jongihlati, Nathan Segall, et al. · Open Forum Infectious Diseases
Works count: 8
Citation count: 23
H-index: 3
I10-index: 1
Year
Topic
Type